Over the years, the number of reports related to berotralstat has shown an increasing trend, rising from 52 in 2021 to 207 in 2024 and 125 in the first 6 months of 2025.
← all excerpts
Hereditary Angioedema Prophylaxis Therapy: Berotralstat and Lanadelumab Safety Profile.
1
—
—